CONTINENTAL STRATEGY, LLC

Lobbying for NRX PHARMACEUTICALS · Clinical biopharma company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · $75,000.00 income · posted Jul 19, 2026

Lobbying activity 1

Pharmacy

Issues regarding lifesaving treatments

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem